Our Mission: Provide the best Independent Toxicologic Pathology Expertise, globally.

Our values of Quality, Timeliness, Diligence & Integrity underpin our mission.

We provide sponsors a valuable option for augmenting their preclinical research capability.

News:

PELLC offering select clients webinars on how "Virtual Preclinical Services" can augment their product development efforts
Dr. Frank Voelker will be giving a workshop on "Image Analysis in Tox Pathology" at STP Annual conference 6/25
William O. Iverson - DVM, Diplomate, ACVP, ABT, joins PELLC as an Expert and as a member of the Executive Team focusing on Business Development in North America. 5/08
PELLC forms Board of Directors, initially consisting of Maurice Cary, CEO, Jack Robinson EVP & investor and John Reddington, outside director. Two additional outside directors will be added. 5/08

Overview:

Pathology Experts LLC Provides senior level preclinical research expertise, in the area of toxicologic pathology, to pharmaceutical and biotechnology sponsor companies.

Our sponsors require the caliber of expertise offered by PELLC to support critical, time sensitive decision making concerning compounds in the preclinical stage of development . Our focus is on delivering high quality and high value service to our clients to meet their corporate milestones.

PELLC provides peer review, troubleshooting expertise, regulatory document preparation, study placement and monitoring. We provide due diligence in support of M&A and licensing activities where detailed assessments of compounds in development represent a significant portion of the value of the transaction. We also perform GLP certified histopathology studies and peer reviews.

PELLC Experts are available for assignments in North America, Europe and Asia.

When it is your most important compound, when it is time critical, when it has to be right the first time, contact Pathology Experts LLC!